The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells
- 10 December 2014
- journal article
- mechanisms of-allergy-and-clinical-immunology
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 135 (4), 1044-1052.e5
- https://doi.org/10.1016/j.jaci.2014.10.032
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- Anti-Allergic Cromones Inhibit Histamine and Eicosanoid Release from Activated Human and Murine Mast Cells by Releasing Annexin A1PLOS ONE, 2013
- Evidence questioning cromolyn's effectiveness and selectivity as a ‘mast cell stabilizer' in miceLaboratory Investigation, 2012
- Increased serum CRH levels with decreased skin CRHR-1 gene expression in psoriasis and atopic dermatitisJournal of Allergy and Clinical Immunology, 2012
- Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in HumansPLOS ONE, 2012
- Mast cells and inflammationBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012
- Calcium signaling in immune cellsNature Immunology, 2008
- Luteolin inhibits myelin basic protein‐induced human mast cell activation and mast cell‐dependent stimulation of Jurkat T cellsBritish Journal of Pharmacology, 2008
- Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1Proceedings of the National Academy of Sciences of the United States of America, 2008
- Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent processProceedings of the National Academy of Sciences of the United States of America, 2006
- Antiallergic Drug Cromolyn May Inhibit Histamine Secretion by Regulating Phosphorylation of a Mast Cell ProteinScience, 1980